Study of Tislelizumab in Combination With Chemotherapy Compared to Chemotherapy Alone for Participants With Urothelial Carcinoma
Clinical trial NCT03967977 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03967977
- Sponsor
- BeiGene
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-29
- Primary completion
- 2027-06-30
- Enrollment
- 420
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.